| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2180 | 2019 |
| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 869 | 2022 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 718 | 2021 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 191* | 2021 |
| Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ ACE project S Moreno‐Grau, I De Rojas, I Hernández, I Quintela, L Montrreal, ... Alzheimer's & Dementia 15 (10), 1333-1347, 2019 | 134 | 2019 |
| A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the … SJ Van Der Lee, OJ Conway, I Jansen, MM Carrasquillo, L Kleineidam, ... Acta neuropathologica 138, 237-250, 2019 | 103 | 2019 |
| GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study A Rongve, A Witoelar, A Ruiz, L Athanasiu, C Abdelnour, J Clarimon, ... Scientific reports 9 (1), 7013, 2019 | 70 | 2019 |
| Detailed stratified GWAS analysis for severe COVID-19 in four European populations F Degenhardt, D Ellinghaus, S Juzenas, J Lerga-Jaso, M Wendorff, ... Human molecular genetics 31 (23), 3945-3966, 2022 | 68* | 2022 |
| Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease D Sánchez, M Castilla-Marti, O Rodríguez-Gómez, S Valero, A Piferrer, ... Scientific reports 8 (1), 16345, 2018 | 60 | 2018 |
| Visual impairment in aging and cognitive decline: experience in a Memory Clinic M Marquié, M Castilla-Martí, S Valero, J Martínez, D Sánchez, ... Scientific reports 9 (1), 8698, 2019 | 52 | 2019 |
| Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study H Saddiki, A Fayosse, E Cognat, S Sabia, S Engelborghs, D Wallon, ... PLoS Medicine 17 (8), e1003289, 2020 | 51 | 2020 |
| Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis N Roberto, MJ Portella, M Marquié, M Alegret, I Hernández, A Mauleón, ... Scientific reports 11 (1), 6448, 2021 | 49 | 2021 |
| Novel genes and sex differences in COVID-19 severity R Cruz, S Diz-de Almeida, M López de Heredia, I Quintela, FC Ceballos, ... Human Molecular Genetics 31 (22), 3789-3806, 2022 | 48 | 2022 |
| PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment L Kleineidam, V Chouraki, T Próchnicki, SJ van Der Lee, ... Acta neuropathologica 139, 1025-1044, 2020 | 47 | 2020 |
| Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI) I de Rojas, J Romero, O Rodriguez-Gomez, P Pesini, A Sanabria, ... Alzheimer's research & therapy 10, 1-12, 2018 | 47 | 2018 |
| Association of rare APOE missense variants V236E and R251G with risk of Alzheimer disease Y Le Guen, ME Belloy, B Grenier-Boley, I De Rojas, A Castillo-Morales, ... JAMA neurology 79 (7), 652-663, 2022 | 43 | 2022 |
| Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers IE Jansen, SJ van der Lee, D Gomez-Fonseca, I de Rojas, MC Dalmasso, ... Acta Neuropathologica 144 (5), 821-842, 2022 | 40 | 2022 |
| Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy … S Moreno–Grau, O Rodríguez‐Gómez, A Sanabria, A Pérez‐Cordón, ... Alzheimer's & Dementia 14 (5), 634-643, 2018 | 35 | 2018 |
| Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative M Marquié, S Valero, M Castilla-Marti, J Martínez, O Rodríguez-Gómez, ... Alzheimer's research & therapy 12, 1-14, 2020 | 32 | 2020 |
| Epilepsy in neurodegenerative diseases: related drugs and molecular pathways A Cano, E Fonseca, M Ettcheto, E Sánchez-López, I de Rojas, ... Pharmaceuticals 14 (10), 1057, 2021 | 31 | 2021 |
